DS
GRI

DRW Securities’s GRI Bio GRI Stock Holding History

DRW Securities’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,593
Closed -$207K – 1406
2025
Q3 		$207K Buy
+3,593
New +$166K ﹤0.01% 1061

Other funds holding GRI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DRW Securities's GRI Position: Q4 2025 in Review

DRW Securities sold out of GRI Bio (GRI) in Q4 2025, closing a stake of 3,593 shares — an estimated $207K sold.

DRW Securities first reported a position in GRI in Q3 2025 and held it in 1 quarter. The position peaked at $207K in Q3 2025. 7 funds tracked by Wall St. Rank hold GRI as of Q4 2025.

  • DRW Securities reported no remaining GRI Bio position as of Q4 2025 after selling out during the quarter.
  • DRW Securities sold 3,593 GRI Bio shares in Q4 2025, an estimated $207K.
  • DRW Securities first reported a position in GRI Bio in Q3 2025 and held it in 1 quarter.
  • DRW Securities's GRI Bio position peaked at $207K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held GRI Bio as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.